Related Experiment Video
Updated: Aug 9, 2026

17:28
Human Pluripotent Stem Cell Based Developmental Toxicity Assays for Chemical Safety Screening and Systems Biology Data Generation
Published on: June 17, 2015
Validation of alternative toxicity test systems: lessons learned and to be learned
1Department of Human Morphology, University of Nottingham Medical School, United Kingdom.
Summary
Thorough reevaluation of in vitro toxicity testing validation is essential for realizing the potential of non-animal testing methods. Developing valid alternatives requires careful consideration of interlaboratory schemes, data comparison, and regulatory acceptance.
Area of Science:
- Toxicology
- In vitro testing
- Regulatory science
Background:
- Validation is crucial for the acceptance of in vitro toxicity tests.
- Current validation practices require critical assessment.
- Non-animal testing methods hold significant promise for toxicity assessment.
Purpose of the Study:
- To define validation in the context of in vitro toxicity testing.
- To discuss key aspects of the validation process.
- To highlight the need for reevaluation to advance non-animal testing.
Main Methods:
- Review of validation processes for in vitro toxicity tests.
- Discussion of interlaboratory validation schemes.
- Analysis of factors influencing validation, including data comparison and test selection.
Main Results:
- Identified critical elements in validation: test/chemical selection, laboratory participation, and in vivo/in vitro data comparison.
- Addressed challenges such as "false" results and the predictive value of cytotoxicity.
- Examined the validation of alternatives to specific animal tests, like the Draize eye irritancy test.
Conclusions:
- A comprehensive reevaluation of current validation practices is necessary.
- Realizing the full potential of non-animal toxicity tests depends on robust validation.
- Developing regulatory-accepted, valid alternative tests requires a thorough review of existing methodologies.

